about
sameAs
Should hormone therapy be recommended for prevention of cardiovascular disease?Uterine artery embolization for symptomatic uterine fibroidsLevonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifenUterine artery embolization for symptomatic uterine fibroidsEndometrial resection and ablation techniques for heavy menstrual bleedingMedical treatments for incomplete miscarriageProgestogens with or without oestrogen for irregular uterine bleeding associated with anovulationEndometrial resection / ablation techniques for heavy menstrual bleedingMedical treatments for incomplete miscarriage (less than 24 weeks)Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifenHormone therapy in postmenopausal women and risk of endometrial hyperplasiaMedical treatments for incomplete miscarriage (less than 24 weeks)Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifenExcisional surgery versus ablative surgery for ovarian endometriomataProgestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulationUterine artery embolization for symptomatic uterine fibroidsMedical treatment for early fetal death (less than 24 weeks)Endometrial destruction techniques for heavy menstrual bleedingExcisional surgery versus ablative surgery for ovarian endometriomataHormone therapy in postmenopausal women and risk of endometrial hyperplasiaRole of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidenceHormone replacement therapy for women previously treated for endometrial cancerMeasurement of androgen and estrogen concentrations in cord blood: accuracy, biological interpretation, and applications to understanding human behavioral developmentHow Is the Number of Primordial Follicles in the Ovarian Reserve Established?Reproduction in females: the role of the early life environmentThe measurement of endometrial perfusion in norplant users: a pilot study.Endometrial destruction techniques for heavy menstrual bleeding: a Cochrane review.Endometrial destruction techniques for heavy menstrual bleeding.Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress.Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles.Long-term progestin contraceptives (LTPOC) induce aberrant angiogenesis, oxidative stress and apoptosis in the guinea pig uterus: A model for abnormal uterine bleeding in humans.Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation.Are autistic traits in the general population stable across development?The impact of uterine radiation on subsequent fertility and pregnancy outcomesReducing depression during the menopausal transition: study protocol for a randomised controlled trial.Endometrial vascular changes and bleeding disturbances with long-acting progestins.Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.Androgen concentrations in umbilical cord blood and their association with maternal, fetal and obstetric factorsVaginal bleeding disturbances and implantable contraceptives.Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.
P50
Q24187045-BC391925-5EC7-4FEE-910D-3B4F3E5466E1Q24187109-D7532CC9-3BB1-43A2-BFCA-EE55532BB454Q24187172-AECA46FB-36F1-42C8-ACC7-ADBACB7488E8Q24197774-69B21921-9A37-41ED-AEE0-7C38B3EF4024Q24199063-EBB60D62-9C67-4BE5-BF4B-A47C9595A24FQ24199141-504B508B-6613-41F2-A32F-4719750672C1Q24200519-4D102D7C-DA8A-48C1-8706-BAF3A67DAE06Q24240135-D4E8263B-610E-4D5B-8574-425E3A242C5BQ24240387-2B66E947-A3BD-4167-9F60-9D84E9F4A9F5Q24240626-B293E04F-3401-4549-844F-9F42AE4F1ED0Q24241713-E53B7B15-37A2-44C2-BF92-F798590898D9Q24242833-F9919046-46D5-4D92-9E18-B3DF2212613BQ24242836-E96071EF-36C6-45F6-92AE-BAE83AA354B1Q24243187-9BD964E7-DF0B-4286-9F77-8EBDEA646446Q24243279-D105D25A-45A3-43B1-B956-D6FD5144A96CQ24244764-92BF1252-38FF-4BA8-A7E0-114ACD2F3238Q24245409-F1BADC42-7E75-405E-A924-2D63064A9B91Q24245703-DC167281-A6C7-4550-9CDF-69A4621119CFQ24246279-39F31F69-E9AE-4EBE-90EA-23B4D6D3F203Q24246573-DF81CAA9-DE7C-41C6-8DC6-4A425809EA3AQ24647700-E1FB4F2E-9567-4546-A99B-F7B17F3AA1D4Q26471218-8967D32D-5914-4546-A3D8-4AAA393BD312Q26825356-4D0AF3F2-FFCE-4AE7-A98C-60D4349DAC7BQ28084803-A0989066-E2D8-4952-B48E-053D6E3932D8Q28296200-48F6F8BA-5670-441E-A352-7AFBE8F229F4Q30653999-BD21495C-E5D9-4CD9-841A-4A3A1410125EQ31116634-552F4AFA-DCBB-41E8-947F-716B1345733CQ32139286-F5C3D791-E5EB-4E13-8BC2-53C9B6B39ADBQ33245945-49EECEC5-4706-4CE7-8415-540811104E85Q33830000-373DAE50-8BEA-4A66-BB7D-D6C12CC07D1EQ33868924-93E3CE73-9D7B-45DF-845B-B054A5E80095Q33909983-04D93712-DA13-4932-9A7C-AC5760D6F955Q33988674-82A9B1FA-A0DB-4140-8020-177DB8A5B9AFQ34073342-1434942E-64A8-43D8-BE73-AC23E45A3E7AQ34084969-51810D79-B411-4B7F-931A-4E6071E7FD5EQ34100041-6FE73CA7-3788-4FF1-9646-D9CB8B574F89Q34349973-D2F05FB9-71F8-4A14-80AF-09BCE8735C4DQ34391063-16631411-B9F9-4C02-91FC-3B5C002FCE03Q34541956-8CA07835-EE51-479B-8B52-E9301DF73668Q34592774-B09674A4-AEF6-4791-8B72-B71CA7019B1A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martha Hickey
@ast
Martha Hickey
@en
Martha Hickey
@es
Martha Hickey
@nl
Martha Hickey
@sl
type
label
Martha Hickey
@ast
Martha Hickey
@en
Martha Hickey
@es
Martha Hickey
@nl
Martha Hickey
@sl
prefLabel
Martha Hickey
@ast
Martha Hickey
@en
Martha Hickey
@es
Martha Hickey
@nl
Martha Hickey
@sl
P108
P106
P108
P1153
55538765300
P21
P31
P496
0000-0002-3941-082X